Concurrent chemoradiotherapy with protracted infusion of 5-fluorouracil (5-FU) and cisplatin for locally advanced resectable esophageal cancer

BACKGROUND: Neoadjuvant concurrent chemoradiotherapy (CCRT) has become the standard treatment for esophageal cancer (EC) in North America. The cisplatin/5-flurouracil (5-FU) combination has been the most commonly used regimen. For the last 15 years we incorporated a daily continuous infusion of 5-FU...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Gastrointest Oncol
Auteurs principaux: Almhanna, Khaldoun, Hoffe, Sarah, Strosberg, Jonathan, Dinwoodie, William, Meredith, Kenneth, Shridhar, Ravi
Format: Artigo
Langue:Inglês
Publié: AME Publishing Company 2015
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4294830/
https://ncbi.nlm.nih.gov/pubmed/25642336
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2078-6891.2014.101
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires